Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix restoration is not a discrete molecular target, but rather the therapeutic goal of repairing or regenerating the ECM, which is a dynamic and complex network of proteins (collagen, elastin, fibronectin, laminin), proteoglycans, and glycosaminoglycans that provides both structural integrity to tissues and essential signaling environments for cellular adhesion, migration, proliferation, and differentiation. ECM restoration is critical in wound healing, surgical recovery, tissue engineering, and diseases characterized by abnormal tissue repair or remodeling. Therapeutic approaches target the balance between ECM synthesis and degradation, aiming to restore or approximate the native architecture and biomechanical properties of healthy tissues, reduce pathological scarring/fibrosis, and optimize tissue function and regeneration.
Inhibition of ECM degradation (e.g., MMP inhibitors); Promotion of new ECM synthesis (e.g., collagen promoters, growth factors); Mechanical stimulation/modulation; Use of scaffolds to provide ECM structure and cues for cell infiltration and repair
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix restoration.